Clinical Trial Update: A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)

View source ↗

Summary

This update reports on a completed non-interventional study collecting clinical characteristics and mortality data of US patients with fibrodysplasia ossificans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Fibrodysplasia Ossificans Progressiva (FOP) | Status: COMPLETED